NUMD'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Nu-Med Plus Inc NUMD'ün son çeyrekteki geliri nasıl performans gösterdi?
Nu-Med Plus Inc'in gelir tahmini nedir?
Nu-Med Plus Inc'in kazanç kalite puanı nedir?
Nu-Med Plus Inc kazançlarını ne zaman rapor eder?
Nu-Med Plus Inc'in beklenen kazançları nelerdir?
Nu-Med Plus Inc kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.0142
Açılış fiyatı
$0.0142
Günün Aralığı
$0.0142 - $0.0153
52 haftalık aralık
$0.0075 - $0.1355
İşlem hacmi
2.2K
Ort.Hacim
5.1K
EPS (TTM)
-0.00
Dividend yield
--
Piyasa Değeri
$1.2M
NUMD nedir?
Nu-Med Plus, Inc. engages in the design, development, and marketing of technologies utilizing nitric oxide in the medical device field. The company is headquartered in Salt Lake City, Utah and currently employs 2 full-time employees. The company went IPO on 2013-08-02. The company focuses on the creation of a nitric oxide (NO) generating formulation, a hospital bedside NO delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. The Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery offers a range of concentrations and flow rates of NO.